TIA1
protein-codingTIA1 cytotoxic granule associated RNA binding protein, the group of RNA binding motif containing
Gene summary
The product encoded by this gene is a member of a RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15-kDa protein that is thought to be derived from the carboxyl terminus of the 40-kDa product by proteolytic processing. Alternative splicing resulting in different isoforms has been found for this gene. [provided by RefSeq, May 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~39.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0030885
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011466
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011466
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0030885
Submitter: ClinGen
*TIA1* was first reported in relation to autosomal dominant amyotrophic lateral sclerosis (ALS) type 26 with or without FTD in 2017 (Mackenzie et al., PMID: 28817800). *TIA1* is an RNA-binding protein involved in the regulation of alternative pre-RNA splicing and mRNA translation by binding to uridine-rich RNA sequences. It also participates in the cellular response to environmental stress by promoting the recruitment of untranslated mRNAs to cytoplasmic stress granules. *TIA1* has also been associated with autosomal dominant Welander distal myopathy. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found difference in phenotypic variability and in molecular mechanism. Despite both diseases being caused by missense mutations in the low complexity domain of *TIA1*, Welander distal myopathy is caused by a founder mutation E384K. There have been no reports of patients with this variant developing ALS. Therefore, the following disease entities have been split into separate disease entities, ALS26 with or without FTD (OMIM:619133) and Welander distal myopathy (OMIM:604454). Five missense variants that have been reported in six probands in four publications (PMIDs: 28817800, 29370934, 29699721, 29773329) are included in this curation. Six other reported missense variants have relatively high minor allele frequencies in population databases (>0.00001 in gnomAD) and were not scored as genetic-level evidence (PMIDs: 28817800 and 29886022). This gene-disease relationship is also supported by experimental evidence. *TIA1* is a component of stress granules and since stress granules play a role in ALS, points were given for biochemical function. Expression studies via immunohistochemistry on lumbar spinal cord of a *SOD1*G86S patient revealed an abundance of *TIA1* positive puncta granules in neuronal and non-neuronal cells; in contrast, *TIA1* immunoreactivity was restricted to the nucleus of motor neurons in controls (PMID: 33025330). In vitro experiments show that ALS associated variants, particularly those that affect proline residues, affect stress granule dynamics by decreasing their mobility and delaying their clearance (PMIDs: 28817800, 34310938). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen ALS GCEP on October 11, 2022 (SOP Version 9).
Inheritance Pattern: SD
Disease ID:MONDO:0030885
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TIA1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022173.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 56 | 3 | 61 | ||
| missense | 2 | 123 | 5 | 130 | ||
| nonsense | 2 | 2 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 5 | 5 | ||||
| splice donor/acceptor (+/-2bp) | 13 | 13 | ||||
| Total | 0 | 2 | 147 | 61 | 3 | 213 |
Highest pathogenic variant AF is 0.000021712023
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071505.2 | 13 | MANE Select | |
| Ensembl | ENSP00000401371.2 | 13 | MANE Select | |
| RefSeq | NP_001338437.1 | 13 | Standard | |
| RefSeq | NP_001338438.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- FGFR2 alternative splicing
- Signaling by FGFR2
- Signal Transduction
- Signaling by FGFR
- Signaling by Receptor Tyrosine Kinases
Biological Process
- apoptotic process
- fibroblast growth factor receptor signaling pathway
- negative regulation of translation
- negative regulation of cytokine biosynthetic process
- regulation of mRNA splicing, via spliceosome
Molecular Function
- RNA binding
- protein binding
- poly(A) binding
- AU-rich element binding
Cellular Component
- nucleoplasm
- cytoplasm
- cytosol
- cytoplasmic stress granule
- nuclear stress granule
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000433529
- Coding exons
- 13
- Length
- 39217
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125747
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.07 | 129 | 214 | 0.602 | 0.0000108 | 2537 |
| Missense (PolyPhen) | 20 | 50.431 | 0.39658 | 608 | ||
| Synonymous | -0.141 | 70 | 68.5 | 1.02 | 0.00000347 | 694 |
| Loss of Function | 3.87 | 7 | 29.8 | 0.235 | 0.00000161 | 306 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000046 | rare |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in alternative pre-RNA splicing and regulation of mRNA translation by binding to AU-rich elements (AREs) located in mRNA 3' untranslated regions (3' UTRs). Possesses nucleolytic activity against cytotoxic lymphocyte target cells. May be involved in apoptosis.;
- Disease
- DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.263
Intolerance Scores
- LoFtool
- 0.354
- RVIS EVS
- 0.24
- RVIS percentile EVS
- 69.21
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.996
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |